- Home
- CSTL vs PGY Comparison
CSTL vs PGY Comparison
Compare CSTL & PGY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CSTL
- PGY
- Stock Information
- Founded
- CSTL 2007
- PGY 2016
- Country
- CSTL United States
- PGY United States
- Employees
- CSTL N/A
- PGY N/A
- Industry
- CSTL Medical Specialities
- PGY Finance: Consumer Services
- Sector
- CSTL Health Care
- PGY Finance
- Exchange
- CSTL Nasdaq
- PGY Nasdaq
- Market Cap
- CSTL 946.1M
- PGY 1.1B
- IPO Year
- CSTL 2019
- PGY N/A
- Fundamental
- Price
- CSTL $29.81
- PGY $9.57
- Analyst Decision
- CSTL Strong Buy
- PGY Strong Buy
- Analyst Count
- CSTL 7
- PGY 9
- Target Price
- CSTL $37.57
- PGY $22.11
- AVG Volume (30 Days)
- CSTL 457.0K
- PGY 2.9M
- Earning Date
- CSTL 11-04-2024
- PGY 11-12-2024
- Dividend Yield
- CSTL N/A
- PGY N/A
- EPS Growth
- CSTL N/A
- PGY N/A
- EPS
- CSTL 0.21
- PGY N/A
- Revenue
- CSTL $311,878,000.00
- PGY $970,898,000.00
- Revenue This Year
- CSTL $49.05
- PGY $25.98
- Revenue Next Year
- CSTL N/A
- PGY $16.03
- P/E Ratio
- CSTL $143.32
- PGY N/A
- Revenue Growth
- CSTL 62.43
- PGY 23.38
- 52 Week Low
- CSTL $16.97
- PGY $8.20
- 52 Week High
- CSTL $35.84
- PGY $20.51
- Technical
- Relative Strength Index (RSI)
- CSTL 45.16
- PGY 44.24
- Support Level
- CSTL $27.24
- PGY $8.20
- Resistance Level
- CSTL $29.02
- PGY $17.20
- Average True Range (ATR)
- CSTL 1.93
- PGY 1.05
- MACD
- CSTL -0.46
- PGY -0.33
- Stochastic Oscillator
- CSTL 29.88
- PGY 15.22
About CSTL Castle Biosciences Inc.
Castle Biosciences Inc is a commercial-stage dermatological cancer company. It is focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The product portfolio of the company includes Cutaneous Melanoma, DecisionDx-Melanoma, DecisionDx-CMSeq, and DecisionDx-PRAME among others.
About PGY Pagaya Technologies Ltd.
Pagaya Technologies Ltd is a financial technology company working to reshape the lending marketplace by using machine learning, big data analytics, and sophisticated AI-driven credit and analysis technology. It was built to provide a comprehensive solution to enable the credit industry to deliver customers a positive experience while simultaneously enhancing the broader credit ecosystem. Its proprietary API seamlessly integrates into its next-gen infrastructure network of partners to deliver a premium customer user experience and greater access to credit. The company generates majority of its revenue from United States.